Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery
Mahdi Abdoli Shadbad, Zahra Asadzadeh, Afshin Derakhshani, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112213-112213
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
Arefeh Zabeti Touchaei, Sogand Vahidi
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 28
Deep Downregulation of PD‐L1 by Caged Peptide‐Conjugated AIEgen/miR‐140 Nanoparticles for Enhanced Immunotherapy
Jun Dai, Jingjing Hu, Xiaoqi Dong, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 18
Closed Access | Times Cited: 62
microRNA-382 as a tumor suppressor? Roles in tumorigenesis and clinical significance
Mehdi Fattahi, Saeid Shahrabi, Fatemeh Saadatpour, et al.
International Journal of Biological Macromolecules (2023) Vol. 250, pp. 125863-125863
Closed Access | Times Cited: 37
Potential of the miR-200 Family as a Target for Developing Anti-Cancer Therapeutics
Hyein Jo, Kyeonghee Shim, Dooil Jeoung
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 5881-5881
Open Access | Times Cited: 28
MicroRNAs as behind-the-scenes molecules in breast cancer metastasis and their therapeutic role through novel microRNA-based delivery strategies
Mohamed J. Saadh, Ashok Kumar Bishoyi, Suhas Ballal, et al.
Gene (2025), pp. 149272-149272
Closed Access
Circ_0000052/miR‐382‐3p axis induces PD‐L1 expression and regulates cell proliferation and immune evasion in head and neck squamous cell carcinoma
Dejun Zhang, Zeming Fu, Yingyuan Guo, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 27, Iss. 1, pp. 113-126
Open Access | Times Cited: 16
A Systematic Review and Meta-Analysis on the Significance of TIGIT in Solid Cancers: Dual TIGIT/PD-1 Blockade to Overcome Immune-Resistance in Solid Cancers
Negar Hosseinkhani, Mahdi Abdoli Shadbad, Mohammad Asghari Jafarabadi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10389-10389
Open Access | Times Cited: 20
Exploring the tumor-suppressive role of miRNA-200c in head and neck squamous cell carcinoma: Potential and mechanisms of exosome-mediated delivery for therapeutic applications
Mohamed S. Kishta, Aya Khamis, Hafez Am, et al.
Translational Oncology (2024) Vol. 51, pp. 102216-102216
Closed Access | Times Cited: 2
A scoping review on the significance of programmed death-ligand 1-inhibiting microRNAs in non-small cell lung treatment: A single-cell RNA sequencing-based study
Mahdi Abdoli Shadbad, Farid Ghorbaninezhad, Hamidreza Hassanian, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 12
Dual silencing of tumor-intrinsic VISTA and CTLA-4 stimulates T-cell mediated immune responses and inhibits MCF7 breast cancer development
Negar Hosseinkhani, Nima Hemmat, Elham Baghbani, et al.
Gene (2023) Vol. 896, pp. 148043-148043
Closed Access | Times Cited: 7
HSV1 microRNAs in glioblastoma development: an in silico study
Mahdi Abdoli Shadbad, Nima Hemmat, Mahla Abdoli Shadbad, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
High-Throughput Sequencing to Investigate the Expression and Potential Role of Differentially Expressed microRNAs in Myocardial Cells after Ischemia-Reperfusion Injury
Senjie Li, Dongqing Lv, Yan Lü, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 1, pp. 38-38
Open Access | Times Cited: 1
<em>miR-19a</em> targeting <em>CLCA4</em> to regulate the proliferation, migration, and invasion of colorectal cancer cells
Huiwen Li, Bo Huang
European Journal of Histochemistry (2022) Vol. 66, Iss. 1
Open Access | Times Cited: 8
The identification of N6-methyladenosine-related miRNAs predictive of hepatocellular carcinoma prognosis and immunotherapy efficacy
Renrui Zou, Yaqian Liu, Sangsang Qiu, et al.
Cancer Biomarkers (2023) Vol. 38, Iss. 4, pp. 551-566
Closed Access | Times Cited: 4
Circulating miRNA Expression Profiles and Machine Learning Models in Association with Response to Irinotecan-Based Treatment in Metastatic Colorectal Cancer
Evangelia Pliakou, Dimitra Ioanna Lampropoulou, Nikolas Dovrolis, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 46-46
Open Access | Times Cited: 7
Microsatellite instability states serve as predictive biomarkers for tumors chemotherapy sensitivity
Taojun Ye, Anqi Lin, Zhengang Qiu, et al.
iScience (2023) Vol. 26, Iss. 7, pp. 107045-107045
Open Access | Times Cited: 3
Recent advances microRNAs and metabolic reprogramming in colorectal cancer research
Bin Xiong, Qiao-yi Huang, Huida Zheng, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
hsa-miR-34a-5p potentiates cytarabine-mediated cell cycle arrest in MDA-MB-231 cells: a novel combination therapy
Saeed Noorolyai, Elham Baghbani, Shima Rahmani, et al.
Pathology - Research and Practice (2022) Vol. 236, pp. 154004-154004
Closed Access | Times Cited: 4
Recent advances in the diagnostic and therapeutic roles of microRNAs in colorectal cancer progression and metastasis
Liang Chen, Jingbo Yang, Xinyi Lin, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Deciphering the miR-200a-3p/RUNX1 Axis: A Novel Oncogene Signature in Colorectal Cancer
Xingkai Su, Xia Jiang, Fangjian Shang, et al.
Research Square (Research Square) (2024)
Open Access
Deep Downregulation of PD‐L1 by Caged Peptide‐Conjugated AIEgen/miR‐140 Nanoparticles for Enhanced Immunotherapy
Jun Dai, Jingjing Hu, Xiaoqi Dong, et al.
Angewandte Chemie (2022) Vol. 134, Iss. 18
Closed Access | Times Cited: 1
The Importance of mir-491-5p in Various Cancers
Mahsa Fakeri, Seyed Masoud Armandzadeh, Samad Sadigh Olyaei, et al.
Current Molecular Medicine (2022) Vol. 23, Iss. 9, pp. 921-933
Closed Access | Times Cited: 1
Identification of a novel Immune-Related prognostic model for patients with colorectal cancer based on 3 subtypes
Xi Yang, Qichun Wei
Immunobiology (2023) Vol. 228, Iss. 2, pp. 152352-152352
Open Access
The Cell Death and Signal Transduction Mechanisms in Colorectal Carcinogenesis: Recent Advances
Monu Kumar Kashyap, Akash Ved, Rajiv Ratan Singh Yadav, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 12, pp. 1361-1375
Closed Access
Dual Silencing of Tumor-Intrinsic VISTA and CTLA-4 Stimulates T-Cell Mediated Immune Responses and Inhibits MCF7 Breast Cancer Development
Negar Hosseinkhani, Nima Hemmat, Elham Baghbani, et al.
(2023)
Closed Access
Page 1 - Next Page

Scroll to top